Epstein-Barr virus (EBV) DNAemia in saliva of viral encephalitis and nasopharyngeal carcinoma patients

被引:0
|
作者
Srinivasan, Nanditha
Barani, Ramya [1 ]
Manickavasagan, M. [2 ]
Srikanth, Padma [1 ]
机构
[1] Sri Ramachandra Univ, Ramachandra Med Coll & Res Inst, Dept Microbiol, 1 Ramachandra Nagar, Chennai, Tamil Nadu, India
[2] Sri Ramachandra Univ, Ramachandra Med Coll & Res Inst, Dept Med Oncol, Chennai, Tamil Nadu, India
关键词
Clinical awareness; Epstein-Barr virus; real-time quantitative PCR; saliva;
D O I
10.4103/ijpm.ijpm_356_23
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Epstein-Barr virus (EBV) is a lymphotropic virus that causes diseases ranging from a flu-like illness called infectious mononucleosis to nasopharyngeal carcinoma, Burkitt's lymphoma, and central nervous system (CNS) infection. Detection of EBV DNA is usually done using whole blood samples taken from the patients. We undertook the detection of EBV in blood, cerebrospinal fluid (CSF), and saliva by real-time quantitative PCR in two patients, one with a history of nasopharyngeal carcinoma, and the other having a case of viral encephalitis. EBV was detected only in saliva, whole blood in both patients, and CSF in the second case tested negative. This case series illustrates the importance of testing for EBV DNAemia in saliva by real-time polymerase chain reaction (PCR) to rule in a diagnosis of EBV.
引用
收藏
页码:208 / 211
页数:4
相关论文
共 50 条
  • [31] Epstein-Barr Virus (EBV)-associated Gastric Carcinoma
    Iizasa, Hisashi
    Nanbo, Asuka
    Nishikawa, Jun
    Jinushi, Masahisa
    Yoshiyama, Hironori
    VIRUSES-BASEL, 2012, 4 (12): : 3420 - 3439
  • [32] Frequency of Epstein-Barr virus and human papilloma virus in patients with nasopharyngeal carcinoma
    Altekin, Ilhan
    Tas, Abdullah
    Yalcin, Omer
    Guven, Selis Gulseven
    Aslan, Zulkar
    Adali, Mustafa Kemal
    Karasalihoglu, Ahmet Rifat
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (07) : 2041 - 2047
  • [33] ANTIBODIES TO EPSTEIN-BARR VIRUS IN PATIENTS WITH NASOPHARYNGEAL CARCINOMA AND IN COMPARISON GROUPS
    NEEL, HB
    PEARSON, GR
    TAYLOR, WF
    ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY, 1984, 93 (05): : 477 - 482
  • [34] INSITU DETECTION OF EPSTEIN-BARR VIRUS MARKERS IN NASOPHARYNGEAL CARCINOMA PATIENTS
    LUNG, ML
    CHAN, KH
    LAM, WP
    KOU, SK
    CHOY, D
    CHAN, CW
    NG, MH
    ONCOLOGY, 1989, 46 (05) : 310 - 317
  • [35] Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis
    Javier S. Burgos
    Medical Oncology, 2005, 22 : 113 - 121
  • [36] Epstein-Barr virus serology in the diagnosis of nasopharyngeal carcinoma
    Wong, MMF
    Lye, MS
    Cheng, HM
    Sam, CK
    ASIAN PACIFIC JOURNAL OF ALLERGY AND IMMUNOLOGY, 2005, 23 (01): : 65 - 67
  • [37] EPSTEIN-BARR VIRUS SEROEPIDEMIOLOGY IN NASOPHARYNGEAL CARCINOMA IN ALGERIA
    ABLASHI, DV
    ALLAL, L
    ARMSTRONG, G
    BOUGUERMOUH, A
    PEARSON, G
    LEVINE, PH
    BENGALI, Z
    EASTON, JM
    ZAGHOUANI, S
    CHOUITER, A
    ALLOUACHE, A
    GHOUADLI, R
    HEAD & NECK SURGERY, 1981, 3 (03): : 257 - 258
  • [38] Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma
    Niedobitek, G
    PATHOLOGE, 1998, 19 (05): : 337 - 344
  • [39] EPSTEIN-BARR VIRUS SEROLOGY IN THE CONTROL OF NASOPHARYNGEAL CARCINOMA
    LEVINE, PH
    CONNELLY, RR
    MILMAN, G
    EASTON, J
    CANCER DETECTION AND PREVENTION, 1988, 12 (1-6): : 357 - 362
  • [40] Nasopharyngeal carcinoma - Epstein-Barr virus serologic testing
    Neel, HB
    HEAD AND NECK CANCER, VOL 4, 1996, : 572 - 577